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Introduction
Malaria remains a major cause of morbidity and mortality both in the tropical and subtropical regions of the world. According to WHO, nearly 214 million cases of malaria occurred globally leading to about 438,000 deaths in 2014 (1) . Pathology and mortality from malaria is due to the blood-stage of the parasite's life cycle, and thus understanding host immune responses to this stage is crucial for the development of effective treatment strategies or vaccines. During the blood-stage of Plasmodium parasite infection, both
CD4
+ and CD8 + T cells are activated (2) (3) (4) . CD4 + T cells are important in mediating protective immunity to eliminate malaria parasites by helping B cells to produce specific antibodies and by activating macrophages and other effector cells (5, 6) . However, excessive T-cell responses during malaria infection often damage normal tissue and lead to immunopathologies such as anemia and cerebral malaria, which in some cases is lethal to the host (7) . To prevent bystander damages to the host, on-going host immune responses need to be controlled during prolonged infection.
After an acute infection, highly functional memory T cells are generated to protect against re-infection with the same pathogen. In contrast, during chronic infection or cancer, T cells show exhausted phenotypes via the expression of inhibitory receptors such as programmed cell death protein 1 (PD-1) (CD279) (8, 9) . PD-1 is induced on T and other immune cells after activation; transduces negative signals and attenuates the activation-signal through T cell receptor (TCR), and thus prevents excessive lymphocyte activation (10, 11) . PD-1 has two ligands; PD-L1, which is constitutively expressed on antigen-presenting cells (APCs) as well as other cells, and PD-L2, which is induced 1 4 mainly on APCs. It was initially shown that virus specific CD8 + T cells in mice chronically infected with lymphocytic choriomeningitis virus (LCMV) are dysfunctional and constitutively express inhibitory receptors including PD-1 (12) . These inhibitory molecules are expressed on exhausted T cells during chronic infection as well as during cancer (8) . Furthermore, in vivo blockade of the interaction of PD-1 with its ligand enhanced T cell proliferation and effector function, suggesting that signaling of inhibitory receptors is directly linked to limiting T-cell function (10, 12) . Subsequent studies have demonstrated that exhausted T cells express multiple inhibitory receptors, whose number and level of expression affect the severity of the dysfunction (8, 13) . However, the role of PD-1 in acute phase of infection is less clear (14) . In experimental models of infection with rabies virus and Histoplasma capsulatum, PD-1 pathway negatively regulated T cell responses and thus inhibited protective immunity (15, 16) , while PD-L1 blockade during acute Listeria monocytogenes infection reduced protective T cell immune responses (17) .
PD-1 and PD-L1 can be induced on both lymphocytes and innate immune cells such as dendritic cells during infection, and the consequences of the interaction appear inhibitory or supportive for the protective immune responses depending on the infection. Another inhibitory receptor, LAG-3 is expressed on activated T cells and its structure is homologous to CD4 (9). LAG-3 binds to MHC II molecules, and negatively regulates the activation and proliferation of T cells (18).
T-cell exhaustion occurs in mouse models of malaria as well as in various chronic protozoan infections (19, 20 
Flow cytometry
Spleen cells were prepared and erythrocytes lysed with Gey's solution, and were stained with APCCy7-anti-CD4 (GK1.5), APC-anti-LAG-3 (C9B7W), PECy7-anti-CD3 
Statistical analysis
Data were analyzed by unpaired 2-tailed Student's t-test using GraphPad Prism6 software (GraphPad Software, La Jolla, CA, USA). population did not express LAG-3, it expressed low levels of PD-1. Since the kinetics of specific T cell responses in L. monocytogenes-infected mice is faster than those infected with P. berghei (4), we monitored the expression of these molecules at an earlier time period after infection with L. monocytogenes (Fig. 2b) . On days 2 and 4 post infection, the levels of CD11a hi CD49d hi CD4 + T cells were 4.3 + 0.7 % and 7.0 + 0.3 %, respectively.
Results
Activated
Although PD-1 expression was highest on day 2 post infection, the expression level was low when compared with that of Plasmodium infection. LAG-3 expression was barely detectable on both days (Fig. 2b) . In mice infected with L. major, we examined CD4 + T cells in the draining lymph nodes, where T cells are primed. Under the experimental condition employed, even though we detected a minor increase in the population of 
Reduced expression of IL-2 by CD4 + T cells in Plasmodium-infected mice
We next examined cytokine production by CD4 + T cells in response to anti-TCR mAb (Fig. 3) . CD4 + T cells from mice infected with the Plasmodium species produced high levels of IFN- but reduced levels of IL-2 when compared with CD4 + T cells from
uninfected mice (Fig. 3a-d) . Although CD4 + T cells from L. monocytogenes-infected mice produced IFN-γ at a high level similar to those from Plasmodium-infected mice, they produced IL-2 at a level comparable to that of uninfected mice in response to anti-TCR mAb (Fig. 3e) . Also, lymph node CD4 + T cells from mice infected with L.
major produced IFN-γ and IL-2 at levels higher than those from uninfected mice (Fig. 3f) .
Taken together, CD4 + T cells from mice infected with Plasmodium species, L.
monocytogenes, or L. major produced higher levels of IFN-γ in response to TCR-stimulation, but only those from Plasmodium-infected mice exhibited a reduced production of IL-2 when compared with those from uninfected mice.
Blockade of PD-1/LAG-3 interactions in vitro
Ligands (Fig. 4a) . Also, IL-2 production by these CD4 + T cells was undetectable in
both blocked and unblocked culture supernatants. As a control group, CD4 + T cells were stimulated with plate-coated anti-TCR mAb without antigen-presenting cells and the effect of these mAbs was evaluated (Fig. 4b) . CD4 + T cells from infected mice did not show enhanced IFN- or IL-2 production when stimulated with plate-coated anti-TCR mAb after blockade (Fig. 4b) . These results imply that antigen-specific activation of -/-and C57BL/6 mice (Fig 5a) . These CD4 + T cells produced IFN- and IL-2 at levels comparable to that of C57BL/6 mice (Fig. 5d) . CD4 + T cells from infected Trif -/-mice also up-regulated PD-1 and LAG-3, and produced high levels of IFN- and reduced levels
of IL-2 (Fig 5b and e) . We did not find significant difference in CD4 + T cell responses between C57BL/6 and Trif -/-mice. We also assessed the involvement of IRF3, which is a major transcription factor that induces type I interferon in response to TLR4 as well as other innate immune receptors (33). While the proportions of CD11a hi CD49d hi CD4 + T cells in Irf3 -/-mice was lower than that of C57BL/6 mice, there were no significant differences in their expressions of PD-1 and LAG-3 (Fig 5c) . Also, the amounts of IFN-γ and IL-2 produced by CD4 + T cells from infected Irf3 -/-mice were comparable to that from infected C57BL/6 mice (Fig 5f) . Of note, the level of parasitemia was slightly higher in infected Irf3 -/-mice than in C57BL/6 mice. Also, no significant difference in parasitemia was observed between infected Myd88 -/-, Trif -/-and C57BL/6 mice ( Fig. 5 legend). These results indicate that the expression of PD-1/LAG-3 on CD4 + T cells, enhanced production of IFN-γ and the reduction in IL-2 production are induced in a manner independent of TLR signaling during infection with Plasmodium parasites; also, type I interferon signaling pathway might be involved in the induction of specific CD4 + T cells in P. berghei infection. 
These results imply that expression of PD-1 and LAG-3 is induced during infection with
Plasmodium parasites, but barely during infection with L. monocytogenes or L. major.
Previous studies in which LCMV was used, showed that PD-1 is transiently expressed on activated CD8 + T cells in acute infection, while it is constitutively expressed on specific CD8 + T cells during chronic infection (12) . This and other studies lead a concept that T cell inhibitory receptors including PD-1 are active inhibitory molecules expressed on exhausted T cells during chronic infection as well as cancer. Our study suggest that the expression of these inhibitory receptors during chronic infection, may not be simply due to the prolonged presence of antigen in vivo, but rather may be due to qualitative Activation status and cytokine production of CD4 + T cells from P. berghei-infected mice are independent of TLR signaling.
Myd88
-/-(a, d), Trif -/-(b, e) and Irf3 -/-(c, f) mice as well as control C57BL/6 mice (WT)
were infected with P. berghei, and spleen cells were analyzed 6 days later. 
